Australia's Cyclopharm gains on US medical technology supply deal

Cyclopharm

14/03/2025 24:21

** Shares of Cyclopharm CYC.AX rise 6.6% to A$1.525, their highest level since February 27

** Radiopharmaceutical co says its signed a 5-year agreement with USA Veterans Administration

** The five-year Federal Supply Schedule (FSS) agreement works to expand co's medical radioactive technology Technegas’ adoption within the US federal healthcare system

** Stock set for second straight session of gains

** CYC up 4.7% YTD

 (Reporting by Adwitiya Srivastava in Bengaluru)

 ((Adwitiya.Srivastava@thomsonreuters.com))